Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study (Q34316681)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study |
scientific article |
Statements
1 reference
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study (English)
1 reference
Isabelle Poizot-Martin
1 reference
Bonaventura Clotet
1 reference
Joseph J Eron
1 reference
Mounir Ait-Khaled
1 reference
Jacques Durant
1 reference
Princy Kumar
1 reference
Gary Richmond
1 reference
Tamio Fujiwara
1 reference
Jenny Huang
1 reference
Sherene Min
1 reference
Cindy Vavro
1 reference
Jane Yeo
1 reference
VIKING Study Group
1 reference
7 December 2012
1 reference
1 reference
207
1 reference
5
1 reference
740-748
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference